跳至主要内容
临床试验/NL-OMON48502
NL-OMON48502已完成不适用

Evaluation of the time dependent variability of the anti-factor Xa activity of therapeutic nadroparin in critically ill patients: a pharmacokinetic study - VARIAXA

Martini Ziekenhuis0 个研究点目标入组 18 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • (1) Admitted to the Intensive Care with nadroparin in therapeutic dose (1-daily
  • or 2-daily)
  • (2) Age * 18 years

排除标准

  • (1) Pregnancy
  • (2) Requiring hemodialysis (HD) or Continuous Veno-Venous Hemofiltration (CVVH)
  • (3) Treated with a DOAC, unfractionated heparin, another LMWH, a GP IIb / IIIa
  • receptor antagonist 96 hours to 0 hours before the first bloodsample is drawn
  • or during bloodsampling.
  • (4) Participation in another study

研究者

相似试验